Winhealth to Market Two Cumberland Pharma Pain Drugs in China

21:57 EDT 15 May 2019 | ChinaBio Today

China's Winhealth Pharma has in-licensed greater China rights for two FDA approved pain management drugs from Cumberland Pharma. Winhealth will have rights to distribute Acetadote® (acetylcysteine) Injection, used to treat liver damage from acetaminophen overdose, and Caldolor® (ibuprofen) Injection, used to treat pain and fever in hospitals. Winhealth currently markets 12 pharmaceutical products in China via partnerships with multinational pharmas and other companies. Established in 2006, Winhealth was founded in Hangzhou and now has its headquarters in Hong Kong. More details....

Stock Symbol: (NSDQ: CPIX)

Share this with colleagues:

Original Article: Winhealth to Market Two Cumberland Pharma Pain Drugs in China

More From BioPortfolio on "Winhealth to Market Two Cumberland Pharma Pain Drugs in China"